Self-reported psoriasis severity and quality of life assessment at Comano spa

Calogero Pagliarello, Anna Calza, Cristina di Pietro, Stefano Tabolli

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The relationship between quality of life (QoL) and skin lesion improvement due to psoriasis treatment has been recently underlined. Our objective was to study the self-reported disease severity reduction and QoL during spa treatments and identify predictors of psoriasis improvement. Patients were assessed before and after spa treatment with a disease-specific QoL questionnaire (Skindex-17) and self-administered psoriasis area and severity index (SAPASI). Their correlations were tested. Factors predicting a reduction in Skindex-17 or in SAPASI score were evaluated through regression analysis. Significant mean overall reductions in SAPASI (27%) and Skindex-17 scores (psychosocial: 6%; symptoms: 2%) were achieved. However, 51% of patients reporting SAPASI improvement also reported a worsened QoL. Pearson's correlation between the SAPASI and Skindex-17 scores was poor (r=0.26 for SAPASI-symptoms and r=0.40 for SAPASI-psychosocial). Logistic regression analysis identified the age of psoriasis onset before 30 years (OR=3.81, 95% CI 1.22-11.95, p=0.02) and a basal Skindex-17 symptoms value greater than 5 (OR=3.37, 95% CI 1.12-10.08, p=0.03) as predictive of both SAPASI and Skindex-17 score reductions. Age-of-onset-based stratification identifies the subset most likely to respond to spa treatment. Combining the Skindex-17 with SAPASI provides a more comprehensive patient-centered assessment. We recommend this assessment for psoriasis patients undergoing spa treatment.

Original languageEnglish
Pages (from-to)111-116
Number of pages6
JournalEuropean Journal of Dermatology
Volume22
Issue number1
DOIs
Publication statusPublished - Jan 2012

Fingerprint

Psoriasis
Quality of Life
Age of Onset
Regression Analysis
Therapeutics
Logistic Models

Keywords

  • Psoriasis
  • Quality of life
  • SAPASI
  • Skindex-17
  • Spa

ASJC Scopus subject areas

  • Dermatology

Cite this

Self-reported psoriasis severity and quality of life assessment at Comano spa. / Pagliarello, Calogero; Calza, Anna; di Pietro, Cristina; Tabolli, Stefano.

In: European Journal of Dermatology, Vol. 22, No. 1, 01.2012, p. 111-116.

Research output: Contribution to journalArticle

Pagliarello, Calogero ; Calza, Anna ; di Pietro, Cristina ; Tabolli, Stefano. / Self-reported psoriasis severity and quality of life assessment at Comano spa. In: European Journal of Dermatology. 2012 ; Vol. 22, No. 1. pp. 111-116.
@article{13c15e356ce6423880679ff3f3d7ccc6,
title = "Self-reported psoriasis severity and quality of life assessment at Comano spa",
abstract = "The relationship between quality of life (QoL) and skin lesion improvement due to psoriasis treatment has been recently underlined. Our objective was to study the self-reported disease severity reduction and QoL during spa treatments and identify predictors of psoriasis improvement. Patients were assessed before and after spa treatment with a disease-specific QoL questionnaire (Skindex-17) and self-administered psoriasis area and severity index (SAPASI). Their correlations were tested. Factors predicting a reduction in Skindex-17 or in SAPASI score were evaluated through regression analysis. Significant mean overall reductions in SAPASI (27{\%}) and Skindex-17 scores (psychosocial: 6{\%}; symptoms: 2{\%}) were achieved. However, 51{\%} of patients reporting SAPASI improvement also reported a worsened QoL. Pearson's correlation between the SAPASI and Skindex-17 scores was poor (r=0.26 for SAPASI-symptoms and r=0.40 for SAPASI-psychosocial). Logistic regression analysis identified the age of psoriasis onset before 30 years (OR=3.81, 95{\%} CI 1.22-11.95, p=0.02) and a basal Skindex-17 symptoms value greater than 5 (OR=3.37, 95{\%} CI 1.12-10.08, p=0.03) as predictive of both SAPASI and Skindex-17 score reductions. Age-of-onset-based stratification identifies the subset most likely to respond to spa treatment. Combining the Skindex-17 with SAPASI provides a more comprehensive patient-centered assessment. We recommend this assessment for psoriasis patients undergoing spa treatment.",
keywords = "Psoriasis, Quality of life, SAPASI, Skindex-17, Spa",
author = "Calogero Pagliarello and Anna Calza and {di Pietro}, Cristina and Stefano Tabolli",
year = "2012",
month = "1",
doi = "10.1684/ejd.2011.1576",
language = "English",
volume = "22",
pages = "111--116",
journal = "European Journal of Dermatology",
issn = "1167-1122",
publisher = "NLM (Medline)",
number = "1",

}

TY - JOUR

T1 - Self-reported psoriasis severity and quality of life assessment at Comano spa

AU - Pagliarello, Calogero

AU - Calza, Anna

AU - di Pietro, Cristina

AU - Tabolli, Stefano

PY - 2012/1

Y1 - 2012/1

N2 - The relationship between quality of life (QoL) and skin lesion improvement due to psoriasis treatment has been recently underlined. Our objective was to study the self-reported disease severity reduction and QoL during spa treatments and identify predictors of psoriasis improvement. Patients were assessed before and after spa treatment with a disease-specific QoL questionnaire (Skindex-17) and self-administered psoriasis area and severity index (SAPASI). Their correlations were tested. Factors predicting a reduction in Skindex-17 or in SAPASI score were evaluated through regression analysis. Significant mean overall reductions in SAPASI (27%) and Skindex-17 scores (psychosocial: 6%; symptoms: 2%) were achieved. However, 51% of patients reporting SAPASI improvement also reported a worsened QoL. Pearson's correlation between the SAPASI and Skindex-17 scores was poor (r=0.26 for SAPASI-symptoms and r=0.40 for SAPASI-psychosocial). Logistic regression analysis identified the age of psoriasis onset before 30 years (OR=3.81, 95% CI 1.22-11.95, p=0.02) and a basal Skindex-17 symptoms value greater than 5 (OR=3.37, 95% CI 1.12-10.08, p=0.03) as predictive of both SAPASI and Skindex-17 score reductions. Age-of-onset-based stratification identifies the subset most likely to respond to spa treatment. Combining the Skindex-17 with SAPASI provides a more comprehensive patient-centered assessment. We recommend this assessment for psoriasis patients undergoing spa treatment.

AB - The relationship between quality of life (QoL) and skin lesion improvement due to psoriasis treatment has been recently underlined. Our objective was to study the self-reported disease severity reduction and QoL during spa treatments and identify predictors of psoriasis improvement. Patients were assessed before and after spa treatment with a disease-specific QoL questionnaire (Skindex-17) and self-administered psoriasis area and severity index (SAPASI). Their correlations were tested. Factors predicting a reduction in Skindex-17 or in SAPASI score were evaluated through regression analysis. Significant mean overall reductions in SAPASI (27%) and Skindex-17 scores (psychosocial: 6%; symptoms: 2%) were achieved. However, 51% of patients reporting SAPASI improvement also reported a worsened QoL. Pearson's correlation between the SAPASI and Skindex-17 scores was poor (r=0.26 for SAPASI-symptoms and r=0.40 for SAPASI-psychosocial). Logistic regression analysis identified the age of psoriasis onset before 30 years (OR=3.81, 95% CI 1.22-11.95, p=0.02) and a basal Skindex-17 symptoms value greater than 5 (OR=3.37, 95% CI 1.12-10.08, p=0.03) as predictive of both SAPASI and Skindex-17 score reductions. Age-of-onset-based stratification identifies the subset most likely to respond to spa treatment. Combining the Skindex-17 with SAPASI provides a more comprehensive patient-centered assessment. We recommend this assessment for psoriasis patients undergoing spa treatment.

KW - Psoriasis

KW - Quality of life

KW - SAPASI

KW - Skindex-17

KW - Spa

UR - http://www.scopus.com/inward/record.url?scp=84857812358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857812358&partnerID=8YFLogxK

U2 - 10.1684/ejd.2011.1576

DO - 10.1684/ejd.2011.1576

M3 - Article

C2 - 22063458

AN - SCOPUS:84857812358

VL - 22

SP - 111

EP - 116

JO - European Journal of Dermatology

JF - European Journal of Dermatology

SN - 1167-1122

IS - 1

ER -